Claim: As the United States government tried to negotiate a response to a novel coronavirus strain, cost issues temporarily stalled passing a bill approving roughly $8 billion in emergency funding.
Verdict: SUPPORTS

Retrieved passages:
title: Pandemic and All-Hazards Preparedness Reauthorization Act of 2013
text: health system to address public health and medical emergencies. Based on information provided by the HHS and the VA, the CBO estimates that implementing the act would cost about $11 billion over the 2014-2018 period, assuming the appropriation of the authorized amounts. The Consolidated Appropriations Act, 2012, included funding totaling about $2 billion in fiscal year 2012 for activities similar to those that would be authorized by H.R. 307. The CBO assumes that amounts appropriated through the Continuing Appropriations Resolution, 2013, for those activities are similar to 2012 levels. H.R. 307 also changes the terms for Project Bioshield contracts, which

title: Sylvia Mathews Burwell
text: Development Authority splitting $152million for the domestic effort. In response to Congressional complaints that the money was not being spent fast enough, Burwell informed Congress that without further funding the CDC's funding to fight Zika would be depleted by September 30, 2016. After Burwell moved funding from other HHS programs, Congress finally appropriated $1.1billion to fight the spread of Zika in the United States. By the end of September 2016, the United States reported 23,000 cases in the territory of Puerto Rico, 3,000 cases in the states, and 21babies born in the United States with microcephaly testing positive for Zika.

title: 2015–16 Zika virus epidemic
text: real-time social media updates are desirable methods for communication during the emergence of infectious diseases. However, misinformation is common and data control in the cyber world has become a growing necessity. Many people criticized the lack of governmental response from the U.S. Government in the wake of the crisis. The United States was criticized for a lack of preparedness in terms of an ability to contain a virus outbreak in the United States. The Obama Administration requested an emergency supplemental appropriation of $1.86 billion for both domestic and international response to the crisis. In response to this request, Congress redirected

title: Pandemic and All-Hazards Preparedness Reauthorization Act of 2013
text: – 2018, which is consistent with the original appropriation of $5.6 billion over FY 2004 – 2013. The new law prohibits SRF funds from being used for anything other than medical countermeasures procurement, research and development. It requires the Secretary of Health and Human Services to provide a report to Congress when funds available in the SRF go below $1.5 billion. It would also allow the use of up to 50 percent of funds available in the SRF for advanced research and development of medical countermeasures at the Biomedical Advanced Research and Development Authority (BARDA). Section 402 reauthorizes BARDA, which

title: Pandemic and All-Hazards Preparedness Reauthorization Act of 2013
text: Secretary of Health and Human Services to enter into contracts and other agreements that are in the government's best interest in meeting identified security countermeasure needs, including reimbursement of the cost of advanced research and development as a reasonable, allowable, and allocable direct cost of the contract involved. It requires that a contract to procure security countermeasures include a clear statement of defined government purpose limited to uses related to a security countermeasure. Section 401 would also reauthorize the Project BioShield Special Reserve Fund (SRF), originally established in 2004. It would reauthorize the SRF at $2.8 billion for FY 2014

title: Influenza pandemic
text: President Bush unveiled the National Strategy To Safeguard Against The Danger of Pandemic Influenza. He also submitted a request to Congress for $7.1 billion to begin implementing the plan. The request includes $251 million to detect and contain outbreaks before they spread around the world; $2.8 billion to accelerate development of cell-culture technology; $800 million for development of new treatments and vaccines; $1.519 billion for the Departments of Health and Human Services (HHS) and Defense to purchase influenza vaccines; $1.029 billion to stockpile antiviral medications; and $644 million to ensure that all levels of government are prepared to respond to

title: 2015–16 Zika virus epidemic
text: $589 million from funds previously dedicated to Ebola instead of allocating new funds. Another criticism regarding Zika funding had to do with the fact that Congress members still took vacation in July 2016 before allocating any of the funds requested in February 2016. In August 2016, the Centers for Disease Control and Prevention reported that they had spent $194 million of the initial $222 million allocation to fight Zika virus. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases said that the NIAID was running out of funds, which would substantially slow down the development of vaccines.

title: Continuing Appropriations Resolution, 2015
text: to existing law and funding levels. "This summary is based largely on the summary provided by the Congressional Budget Office, a public domain source." This resolution would provide funding through December 11, 2014, except for $88 million to respond to the Ebola virus, which would be available until September 30, 2015 (sections 136 and 137). In addition, section 147 would continue the authorization for the Export-Import Bank of the United States through June 30, 2015. All other amounts are shown on an annualized basis. These amounts are subject to discretionary spending limits in the Balanced Budget and Emergency Deficit Control

title: Biodefense and Pandemic Vaccine and Drug Development Act of 2005
text: responsibility for developing bioterrorism countermeasures out of the Department of Homeland Security and into the new BARDA agency within the Department of Health and Human Services. The proposed new agency would improve on Project BioShield, a barely two-year-old program also meant to encourage production of vaccines and drugs. BARDA would receive a first-year budget of $1 billion. Other key aspects of the proposed legislation include: Much of the support for the bill comes from Pharmaceutical Research and Manufacturers of America (PhRMA) and its members. In the 2002 election cycle, PhRMA contributed $3,505,052 to politicians, with 95% going to Republicans. The

title: 2015–16 Zika virus epidemic
text: Although the government faced criticism for not responding strongly enough to the Zika outbreak, the government eventually provided funding of $1.1 billion for Zika in October 2016. It took congress nearly seven months to agree to this allocation, which left many prevention and education projects without funding for a substantial amount of time. Senate Democrats urged Republicans to approve the full amount of funding more quickly rather than waiting for major transmission of Zika virus to begin in the United States. In 2017, public health experts are still concerned about the failure of the Zika response in the United States.

title: Antimicrobial resistance
text: issue up to $62 million from 2013 to 2019. Using authority created by the Pandemic and All Hazards Preparedness Act of 2006, the Biomedical Advanced Research and Development Authority in the U.S. Department of Health and Human Services announced that it will spend between $40 million and $200 million in funding for R&D on new antibiotic drugs under development by GlaxoSmithKline. Antimicrobial susceptibility testing (AST) can help practitioners avoid prescribing unnecessary antibiotics in the style of precision medicine, and help them prescribe effective antibiotics, but with the traditional approach it could take 12 to 48 hours. Rapid testing, possible from

title: Infectious Diseases Society of America
text: patients due to fear of drug resistance. These economic and regulatory disincentives have made it far too difficult for companies to continue developing new antibiotics. It is estimated that the cost to the U.S. health care system of antibiotic resistant infections is $21 billion to $34 billion each year and more than 8 million additional hospital days. On May 1, 2011, IDSA published a policy paper titled "Combating Antimicrobial Resistance: Policy Recommendations to Save Lives" in Clinical Infectious Diseases. The paper detailed the organization's recommendations for specific public policy strategies and research activities needed to promote the best interests of

title: Public Readiness and Emergency Preparedness Act
text: purview of the secretary of Health and Human Services (HHS). PREPA provides $3.8 billion for pandemic influenza preparedness to protect public health in the case of a pandemic disease outbreak. Vaccine manufacturers lobbied for the legislation, which would effectively preempt state vaccine safety laws in the case of an emergency declaration by HHS, by making clear they would not produce new vaccines unless the legislation was enacted. Legislative leaders Senator Bill Frist and Congressman Dennis Hastert were among the backers of PREPA legislation, which was tacked onto the end of a defense-spending bill (HR 2863). Of the $3.8 billion earmarked

title: Sylvia Mathews Burwell
text: low. In February 2016, in response to the spread of the Zika virus, the Obama administration requested that Congress appropriate $1.9billion to fight the spread of the disease. Congress did not initially take action, leaving Burwell to direct the Department of Health and Human Services to reprogram $589million in funds previously designated as part of the response to Ebola, to fight the spread of the Zika virus. Of the initial Zika funding, the Centers for Disease Control (CDC) received $222million to lead the domestic fight against the virus with the National Institutes of Health and the Biomedical Advanced Research and

title: 2005 United States federal budget
text: proposes an additional $8.3 million, a near 40% increase, to enhance FDA enforcement of Federal regulations to prevent the introduction or spread of bovine spongiform encephalopathy • proposes a four-year $300 million Prisoner Re-Entry initiative • proposes doubling the Access to Recovery program to $200 million • proposes more than doubling resources for the Compassion Capital Fund, ($100 million) • proposes $50 million for mentoring children of prisoners • proposes over $1 billion for the Corporation for National and Community Service; includes $442 million to support 75,000 AmeriCorps members; • proposes $225 million to expand the National Senior Service Corps

title: Sylvia Mathews Burwell
text: from Ebola in the United States occurred. The Obama administration proposed devoting $6billion to fight the spread of Ebola, including $2billion for the State Department and USAID. The plan included provisions to help U.S. hospitals become better prepared and to support global health initiatives aimed at containing the disease in Africa. Congress allocated $5.4billion to fight Ebola in response to the Obama administration request. Burwell and other Obama administration officials sought to assure the public that the American health system was prepared to deal with Ebola cases and that the chances of a full outbreak in the United States were

title: University of Wisconsin–Madison
text: federal government. In June 2013, it is reported that the United States National Institutes of Health would fund an $18.13 million study at the University of Wisconsin. The study will research lethal qualities of viruses such as Ebola, West Nile and influenza. The goal of the study is to help find new drugs to fight of the most lethal pathogens. In 2012, UW-Madison experiments on cats came under fire from People for the Ethical Treatment of Animals who claimed the animals were abused. In 2013, the NIH briefly suspended the research's funding pending an agency investigation. The following year the

title: Prizes as an alternative to patents
text: both the government and private insurance companies to fund the "Medical Innovation Prize Fund". According to the S1137 bill, the innovation fund would create a fund of .55% of GDP, $80 billion of GDP based on 2010 numbers. S1138 calls for a .02% GDP fund for HIV/AIDS innovation prizes that amounts to about $3 billion a year. In a statement made at a subcommittee meeting, Senator Sanders said, "It simply blew me away — and would blow anyone’s mind away — that one drug, Atripla, costs $25,000 per year". He called this bill, “Fairly radical for the U.S. Congress.” According

title: Infectious Diseases Society of America
text: On November 3, 2017, the U.S. House passed a bill, H.R. 3922 (the "CHAMPIONING Healthy Kids Act") that cuts $6.35 billion from the Prevention and Public Health Fund (PPHF). Dr. Paul Auwaerter, president of IDSA, said that the cut would hurt both public health and national security. The PPHF fund comprises over 12 percent of the budget of the Centers for Disease Control and Prevention (CDC). Auwaerter said, "…a significant cut to the fund will have a very troubling impact on CDC efforts to prevent infections and respond to outbreaks in communities and health care settings." The PPHF was created

title: Pandemic and All-Hazards Preparedness Reauthorization Act of 2013
text: was created in 2006 to help bridge the gap between medical countermeasures development and procurement. It would reauthorize BARDA at $415 million for FY 2013 – 2017, which is equal to the program's FY 2012 appropriated level. The Secretary of Health and Human Services is instructed to support innovation under BARDA by promoting dose sparing technologies, efficacy increasing technologies, and platform technologies. Section 402 also extends the Freedom of Information Act (FOIA) exemption for specific technical data or scientific information that is created or obtained during countermeasure and product advanced research and development under the Public Health Service Act that